bpsbioscience

About

BPS Bioscience's purpose is to advance new scientific discoveries that lead to therapies by creating innovative solutions for research. Founded in 2005 by Henry Zhu, Ph.D., the company has grown to become a leading developer and manufacturer of research tools for drug discovery, specializing in areas such as immunotherapy, CAR-T therapy, epigenetics, CRISPR, cell signaling pathways, and coronavirus research. Headquartered in San Diego, California, BPS Bioscience offers a comprehensive portfolio of over 4,000 products including recombinant proteins, assay kits, cell lines, lentiviruses, and viral tools. The company's expertise spans diverse scientific fields including bromodomains, deacetylases, demethylases, kinases, methyltransferases, phosphodiesterases, phosphatases, poly ADP ribose polymerases, and ubiquitin enzymes. BPS Bioscience provides custom protein expression, biochemical and cell-based assays, cell line development, CRISPR, BLI, and compound screening services to accelerate drug discovery and development for the treatment of human diseases.